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ABSTRACT
Cognitive bias is a phenomenon that presents in clinical populations where anxious
individuals tend to adopt a more pessimistic interpretation of ambiguous aversive stimuli and
depressed individuals not only tend to adopt a more pessimistic interpretation of ambiguous
aversive stimuli, but also a less optimistic interpretation of ambiguous appetitive stimuli. Such
biases have also been pharmacologically reversed in clinical trials. To measure cognitive bias in
the chick anxiety-depression continuum model, chicks exposed to an isolation stressor of 5 min
to induce an anxiety-like or 60 min to induce a depressive-like state were then tested in a straight
alley maze to a series of morphed ambiguous appetitive (chick silhouette) to aversive (owl
silhouette) cues. In non-isolated controls, runway start and goal latencies generally increased as
a function of greater amounts of aversive characteristics in the cues. In chicks in the anxiety-like
state, runway latencies were increased to aversive ambiguous cues, reflecting more pessimisticlike behavior. In chicks in the depression-like state, runway latencies were increased to both
aversive and appetitive ambiguous cues, reflecting more pessimistic-like and less optimistic-like
behavior, respectively. The current study sought to be able to pharmacologically reverse this
cognitive endophenotype which would serve as a further validation step for the model as a
neuropsychiatric simulation of anxiety and depression.
Experiment 1 was conducted to ensure that drug treatments, clonidine and imipramine, do
not substantially influence cognitive decision making to natural and ambiguous appetitive and
aversive stimulus cues in the social treatment condition. Experiment 1 consisted of three socially
tested groups (previous studies have shown that chicks tested with two cagemate conspecifics
display relatively low levels of stress). Each group was administered either 0.15mg/kg clonidine
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(tested for 5-min indicative of the anxiety-like phase), 15mg/kg Imipramine (tested for 60-min
indicative of the depression-like phase), or a physiological saline (tested for 60-min to serve as
the control) prior to apparatus testing. Distress vocalizations (DVocs), a dependent measure for
stress, were collected for each condition. Following apparatus testing, chicks were tested
immediately in the maze under four stimulus cue conditions: mirror, 25c:75o morph, 75c:25o
morph: and 0c:100o (owl silhouette). To assess a baseline for each stimulus cue, a no-isolation
apparatus test control group was administered saline and tested immediately within the maze.
Dependent measures were start and goal latencies and farthest distance traveled and the maze
cutoff criterion was 5 min.
Although it was not predicted, the patterns of DVocs observed in anxiety-like and
depression-like phases of socially tested chicks were consistent with previous studies in which
isolated chicks exhibit a specific pattern of behavioral responses and responses to drug treatment
in the anxiety-like and depression-like phases. Because differences exist in DVoc rates between
drug groups for socially treated chicks, it appears that the chicks are experiencing some
measurable amount of stress even within the social isolation manipulation which may be
attributable to factors such as novelty to testing apparatus and flock reduction.
Consistent with the modest stress patterns observed in the DVoc data, chicks exhibited a
modest amount of cognitive bias within the maze, more specifically under the ambiguous
stimulus cues and not the mirror or the owl stimulus cues. In general, chicks in the depressionlike phase displayed more pessimistic behavior under the aversive and ambiguous aversive
stimulus cues (25c:75o and 0c:100o) and also less optimistic behavior under the appetitive and
ambiguous appetitive stimulus cues (mirror and 75c:25o) under mean start latency and mean
distance traveled. Both forms of cognitive bias were reversed by imipramine under these two
iii

dependent measures. Although these findings were unexpected, they are consistent with the
DVoc patterns observed. Given these unexpected findings the vehicle no-test group was chosen
to be the main control group for Experiment 2.
One additional finding was that for the anxiety-clonidine group, start latencies under the
mirror, 75c:25o, and 25c:75o stimulus cues were significantly shorter compared to the vehicle
isolation-test group and mean distance traveled under the 25c:75o stimulus cue was significantly
shorter compared to the vehicle isolation-test group. One explanation for these observed effects
could be that clonidine at a dose of 0.15mg/kg produced observable sedative effects within the
runway; therefore, the dose of clonidine administered in Experiment 2 was decreased to
0.10mg/kg to lessen the likelihood of sedation.
Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a
depression-like phase and to test whether those cognitive biases could be pharmacologically
reversed. Experiment 2 followed the same procedures as Experiment 1 with three exceptions: 1)
a new treatment condition, a vehicle 5-min isolation group to use as a control for the anxietyclonidine group; 2) lowering the dose of clonidine from 0.15mg/kg to 0.10mg/kg to lessen the
likelihood of sedation within the runway; and 3) the induction of the isolation produce within the
testing apparatus. All dependent measures remained the same.
In general, chicks in the depression-like phase displayed more pessimistic behavior under
the aversive and ambiguous aversive stimulus cues (25c:75o and 0c:100o) and also less
optimistic behavior under the appetitive and ambiguous appetitive stimulus cues (mirror and
75c:25o) under mean start latency and mean distance traveled. Both forms of cognitive bias
were reversed by imipramine under these two dependent measures. Chicks in the anxiety-like

iv

phase displayed more pessimistic behavior under the aversive and ambiguous aversive stimulus
cues (25c:75o and 0c:100o) under mean start latency. However chicks that were administered
clonidine tended to display sedation under mean start latency and mean distance traveled despite
lowering the dose.
Collectively, the observation that cognitive biases of both more pessimism and less
optimism present within the single test paradigm of anxiety and depression and can be
pharmacologically reversed in the depression-like phase adds to the validity of the chick anxietydepression model as a neuropsychiatric simulation. The chick anxiety depression model, along
with the runway test to ambiguous appetitive and aversive cues, may lend itself to exploring the
common neurophysiological mechanisms subserving cognitive disturbances and
pharmacological responses seen in these two seemingly related clinical disorders.
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Running Head: PHARMACOLOGOCAL REVERSAL OF CONGNITIVE BIAS

Pharmacological Reversal of Cognitive Bias in the
Chick Anxiety-Depression Continuum Model

Anxiety and depression are two very common and detrimental mental health disorders.
Anxiety affects approximately 40 million Americans, ages 18 years and older, while depression
affects 14.8 million Americans (National Institute of Mental Health, 2009a) and 150 million
people worldwide (World Health Organization, 2003). Further, with comorbidity rates ranging
from 50 to 90%, many patients suffer a concurrent presentation of anxiety and depression
(Kessler, Berglund, Demleer, Jin, Merikangas, & Walters, 2005; Kessler, McGonagle, Zhao,
Nelson, Hughes, & Eshleman, 1994; R. A. Rivas-Vazquez, Saff-Biller, Ruiz, Blais, A. RivasVazquez, 2004). Approximately 85% of people suffering from depression will present symptoms
of anxiety and 90% of people suffering from anxiety will present symptoms of depression
resulting in even further debilitation (Gorman, 1996-1997).
Depression is the primary cause of disability in the United States for ages 15-44
(National Institute of Mental Health, 2009a) and is the third largest contributing factor to the
global burden of disease (World Health Organization, 2003). In addition to the toll on the
quality of life, mental disorders produce immense financial strains associated with treatments,
reduced productivity, increased incarceration, and increased mortality rates that not only the
patient, but also society must endure (Surgeon General, 1999; World Health Organization, 2003).
In the United States, there is an estimated $193 billion annual income deficit for all mental
disorders (Kessler et al., 2008; National Institute of Mental Health, 2009b); $53 million is
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estimated from depression alone (Greenburg, et al., 1996). However, a more imperative issue is
the significant population of patients that are unaffected by or experience serious side effects
with the current therapeutic options (Davidson & Conner, 2004; Krishnan, 2004; Nelson, 2004;
Rosenbaum & Tollefson, 2004), thus creating a need for more efficacious treatments with fewer
side effect profiles. Advancements in novel pharmacological therapies for anxiety and
depression, as well as other psychiatric disorders, heavily rely on the development, validation
and utilization of animal models.
According to Willner (1991a), there are three types of animal models which include
screening assays, behavioral bioassays, and simulations. Screening assays evaluate and compare
the drug action of novel compounds with known compounds to identify potential clinical uses
(e.g., antidepressant or anxiolytic effects). Since they are solely concerned with observing a
positive or negative outcome analogous to clinical trials, screening assays must only adhere to
predictive validity. Predictive validity is the degree to which a model can accurately predict the
performance of novel or known drug actions based on the outcome observed. Behavioral
bioassays examine the physiological functions underlying a particular behavior or disorder and
it’s response to drug treatments. In addition to examining the mechanisms that alter brain
functioning due to a disorder or treatment, behavioral bioassays are also able to identify novel
physiological targets for drug development. These models are subject to construct validity: the
theoretical rationale upon which the model is founded and asks a variety of questions narrowing
down to, “Does the model correctly measure the characteristics associated with the human
disorder.” Simulations are intended to mimic a disorder by assessing behaviors relative to a
particular species and disorder to determine the etiology, physiological foundations, and
responses to drug treatments. For a simulation to correctly model a clinical disorder, it is to
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adhere not only to predictive and construct validity, but also face validity. Face validity
evaluates the similarity between the model and the actual human disorder in terms of the
etiology, physiology, symptomatology, and treatment effects. The simulation and the disorder
should have as many similarities as possible and the face validity is subject to change as new
information arises (Willner, 1991a). In addition to being characterized by these three types of
validity, animal models should also adhere to the principles of generalizability and
reproducibility (Miczek & Wit, 2008; van der Staay, 2006).The utilization of sound animal
models has led to significant advances in our knowledge and treatment of anxiety and depression
(Willner, 1991a).
Traditional animal models of anxiety induce anxiety-like symptoms using conflict and/or
conditioned or unconditioned responses to threat. Anxiety models also use exploratory
paradigms such as the open field test, elevated plus maze, holeboard and light-dark box (for
review see, Bourin, Petit-Demoulie`re, Dhonnchadha & Hascoäet 2007; Ladner, 1991). Such
tests are designed to measure avoidance, the latency period to perform the task, which is
increased with stress-inducing stimuli or situations, and reduced after the administration of
anxiolytic drugs (Green & Hodges, 1991). Most animal models of depression employ either
stress (e.g., chronic mild stress), learned helplessness (e.g., forced swim test), or separationisolation paradigms to engender depressive-like characteristics in animals (for review see,
Willner, 1991b). Animal models of depression attempt to mirror the characteristics of the human
disorder, to examine the drug-induced behavioral changes and the neurochemical effects
(McArthur & Borsini, 2006). Animal models help us to understand and treat anxiety and
depression by identifying of the disorders’ multifaceted symptom profiles determining the
etiological foundations which initiate the development of more target specific drug treatments,
3

and facilitating research of the physiological responses to novel therapeutic drug treatments
(Ladner, 1991). However, despite these advances, many criticisms of animal models have been
recently raised.
Kalueff, Wheaton, and Murphy (2007) offer a number of criticisms of current rodentbased models of anxiety and depression. First, animal models provide questionable within- and
between-laboratory reliability owing to varying results. A second criticism of animal models is
the constraints of species-specific behaviors through artificial environments (e.g., exploratory
paradigms); which often restrict the environment so any movements may be due solely to the
environment, not necessarily innate behaviors (Whishaw, Gharbawie, Clark, & Lehmann, 2006).
Other criticisms include an over emphasis on either internal genetic (e.g., strain differences) or
external epigenetic (e.g., environmental) factors. Lastly, these authors as well as Frazer &
Morilak (2005) suggest that animal models should attempt to simulate the multi-syndromal
aspect of anxiety and depressive disorders (Frazer & Morilak, 2005; Kalueff et al.,2007) due to
the increasing amount of data showing high comorbidity rates between anxiety and depressive
disorders (Gorman, 1996-1997; Kessler et al., 1994, 2005; Rivas-Vazquez et al., 2004).
Because the comorbid presentation rates of anxiety and depression are so prevalent
(Gorman, 1996-1997; Kessler et al., 1994, 2005; Rivas-Vazquez et al., 2004), the two disorders
are now suggested to be on a single continuum (Kasper, 2001). The anxiety-depression
continuum theory states that anxiety and depression are different temporal facets due to repeated
stressors with anxiety-like symptoms preceding depression-like symptoms (Kasper, 2001).
However, current animal models of anxiety and depression examine the two disorders separately,
so as to mirror the classification by the Diagnostic and Statistical Manual of Mental DisordersIV (American Psychiatric Association, 1994). Owing to the recent data showing high
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comorbidity rates, current animal models are not producing adequate information to treat anxiety
and/or depression. To resolve this lack of sufficient animal models, Kalueff et al., (2008, 2007)
suggest a “hybridization” of anxiety and depression models.
Sufka et al. (2006) proposed such a “hybrid” model to examine the anxiety-depression
continuum theory by combining two paradigms that measured the same behavioral response,
distress vocalizations, to a social isolation stressor in domestic fowl chicks (Lehr, 1989;
Panksepp, Vilberg, Bean, Coy, & Kastin, 1978; Panksepp, Meeker, & Bean, 1980; Panksepp,
2003). This “hybrid” model, the chick anxiety-depression continuum model, involves isolating
chicks from conspecifics and measuring the distress vocalizations (DVocs) over a 2-hour test
session which reveals both an anxiety-like phase and a depression-like phase within a single
paradigm (Sufka et al., 2006). Within the first 5-min of isolation, DVocs rates are relatively high
which is indicative of an anxiety-like (panic-like) state whereby chicks attempt to reestablish
social contact. In the next 20-25 min of isolation, DVoc rates display a steady decline which is
characterized as a transitional period. In the final 30-120-min of isolation, DVocs reach a
plateau of approximately 50% of the initial rate which is characteristic of a depression-like state
(i.e., behavioral despair).
In addition, the anxiety- and depression-like phases can be pharmacologically dissociated
by administering diverse compounds possessing anxiolytic and antidepressant effects.
Compounds with anxiolytic effects (e.g., chlordiazepoxide, clonidine, and imipramine) attenuate
the high DVoc rates during the anxiety-like phase, whereas compounds with antidepressant
effects (e.g., imipramine, maprotiline, and fluoxetine) attenuate the reduction in DVoc rates
during the depression-like phase (Sufka et al., 2006; Warnick, Huang, Acevedo & Sufka, 2009).
Further, common stress and depression biomarkers present within the model and include
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elevated corticosterone and interleukin-6 (IL-6) levels (Sufka et al., 2006; Warnick et al., 2009).
A recent study that efficacy screened 7 compounds targeting novel CNS sites, each of which
previously passed antidepressant screening in rodent models, yielded a somewhat different
profile than those early pre-clinical screens. The chick anxiety-depression model identified
prasterone, ketamine, mifepristone, CGP36742 and DOV216,303 as possessing antidepressant
properties while memantine and antalarmin did not (Sufka et al., 2009). Interestingly, this pattern
of effects is in line with early clinical trial outcomes and illustrates the predictive validity of the
model by correctly detecting efficacy of some compounds while avoiding two false positives
(Wolkowitz et al., 1999; Zarate et al., 2006a; Zarate et al., 2006b; Belanoff et al., 2002;
Schechter et al., 2005). Collectively, these results begin to provide support for the validity of the
model as a neuropsychiatric simulation and screening assay.
Further enhancing the validity of the chick anxiety-depression model requires
strengthening the amount of connections made between the model and the clinical presentation
of anxiety and depression (Miczek & Wit, 2008; Panksepp, 2006; van der Staay, 2006;). An
approach to this type of enhancement is through quantifying behavioral endophenotypes which
are defined as “a set of behavioral and/or physiologic characteristics that accompany a basic
process that is altered in relation to the illness that is being studied” (Bakshi & Kalin, 2002). The
use of endophenotypes must occur in a top-down fashion whereby the characteristics that make
up the human clinical disorder are translated and understood within the natural behavior of the
model species (i.e., domestic chicks) (van der Staay, 2006). Humans suffering from anxiety
and/or depression have demonstrated the endophenotype of cognitive disturbances and being
able to quantify similar kinds of cognitive disturbances in the chick anxiety-depression model
can strengthen this paradigm as a neuropsychiatric simulation (Kalueff & Murphy, 2007).
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Cognitive bias is a phenomenon that presents in individuals suffering from anxiety and/or
depression in which cognitive disturbances elicit negative interpretations of ambiguous stimuli
and/or events. More specifically, anxiety is associated with increased negative expectations of
future events, known as more pessimism, whereas depression is associated with both increased
negative expectations and also decreased positive expectations of future events, known as less
optimism (Wright & Bower 1992; MacLeod & Byrne 1996). Further, both anxious and
depressed individuals make more negative interpretations of themselves (Beck, 1963 as cited in
Clark & Beck, 1999), and negative interpretations of future (Butler & Mathews, 1983, 1987)
and/or current events (Schwarz & Clore, 1983) for themselves and others (Alloy & Ahrens,
1987). In his cognitive model of psychopathology, Beck (1976) proposed that such cognitive
disturbances are not only a product of, but may also play a role in maintaining anxiety and
depression due to the constant processing of negative information and negative recurring
thoughts. Therefore understanding the behavioral processes of such cognitive disturbances may
help to reduce the severity of anxiety and/or depression.
In a study that clearly showed the cognitive biases associated with anxiety and
depression, Miranda & Mennin (2007) assessed participants’ predictions of future events.
Participants completed a questionnaire which contained positive and negative future events for
which they were to indicate “yes” or “no” the event would likely to occur to them and then how
certain they were. Both anxious and depressed individuals were more pessimistic in their beliefs
about negative events occurring to them; however only depressed individuals were less
optimistic in their beliefs of positive events occurring to them (Miranda & Mennin, 2007). These
results are consistent with a study by MacLeod & Byrne (1996) in which anxious individuals
showed an increase in expectations of negative events and depressed individuals showed both an
7

increase in expectations of negative events and decreased expectations of positive events for
events occurring presently, in a week, or in 5-10 years.
There have been several paradigms used to measure the effects of cognitive bias in
anxious and depressed individuals including interference tasks, attentional probe tasks and
homophone tasks (for review see, Mathews & MacLeod, 1994; Mogg & Bradley, 2005). The
most common cognitive interference task is a modified version of the Stroop Task wherein the
words presented in colored ink are either neutral or threat-related words (e.g., collapse, death,
and failure), and the participant is to respond with the content of the word rather than the color.
Anxious individuals displayed longer latencies for the color-naming of threat-related words as
compared to neutral words; indicating that the threat-related words create a greater cognitive
interference relative to the neutral words relative to than threat-related or neutral words
(Matthews and Macloed, 1985). Whereas depressed individuals displayed greater latencies when
color-naming negative self-descriptive or negative socially-related words relative to neutral
words (Mogg & Bradley, 2005) (Mathews & MacLeod, 1994); they also displayed greater
latencies when color-naming depressed-related words relative to neutral- or manic-related words
(Gotlib & McCann, 1984).
To assess the performance of patients with concurrent generalized anxiety disorder
(GAD) and depression, Bradley, Mogg, Millar, & White (1995) used the Stroop Task with
anxiety-related (e.g., disgrace, cancer), depression-related (e.g., misery, discouraged),
categorized neutral (household terms, e.g., carpet, domestic) or uncategorized neutral (e.g.,
geometry, exchange) words in either supraliminal or subliminal conditions. The results revealed
that GAD participants without concurrent depression displayed longer color-naming latencies for
the anxiety-related words relative to the neutral words, more so than the participants with GAD
8

and concurrent depression. In addition, the GAD participants without concurrent depression
displayed longer color-naming latencies for anxiety- and depression-related words relative to
neutral words in both supraliminal and subliminal conditions.
To assess cognitive bias in the attention of anxious and depressed individuals, visual
probe tasks are utilized. In these tasks, word pairs, one negative and one neutral word, are
presented on a computer screen and followed by a small dot probe presented in the area where
either the negative or neutral word had appeared. Anxious individuals displayed faster probe
detection of dots presented in the negative word location as compared to the neutral word
location, suggesting that anxious individuals allocate more attention to the negative stimuli
whereas controls tended to shift attention from the negative probes. In contrast, depressed
individuals did not display differences in probe detection latencies presented in either the
negative or neutral word location (MacLeod, Mathews, & Tata, 1986).
Cognitive biases in anxiety and depression can also be observed using the homophone
task wherein a previously recorded audio tape presents ambiguous homophones differing in
spelling and emotional valance, either threat-related or neutral words (e.g., die/dye or guilt/gilt).
Anxious individuals (Eysenck, MacLeod, & Mathews, 1987; Mathews, Richards, & Eysenck,
1989) as well as depressed individuals (Mogg, Bradbury, & Bradley, 2006) reported a higher
number of threat-related rather than neutral homophones when compared to non-anxious
controls. In addition, anxious individuals also displayed greater amounts of skin conductance
responses to threat-related stimuli than to neutral-stimuli during the homophone task when
compared to controls (Mathews et al., 1989). Similar studies have also found a negative
interpretation bias in anxious individuals using a modification of the RSVP paradigm which
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presents either ambiguous passages (MacLeod & Cohen, 1993) or ambiguous sentences
(Eysenck, Mogg, May, Richards, & Mathews, 1991).
Interestingly, cognitive bias is sensitive to a variety of therapies affecting mood
disturbances. For example, Cognitive Behavioral Therapy (CBT) has been shown to reverse the
negative interpretation bias in patients treated for generalized anxiety disorder patients (without
concurrent depression) (Mogg, Bradley, Millar, & White, 1995). Participants were tested twice,
two months apart, using the modified Stroop task with anxiety-related (e.g., disgrace),
depression-related (e.g., discourage) and neutral words (e.g., domestic) in masked, replaced with
a letter string, and unmasked exposure conditions. In first test session the anxiety participants
displayed longer color-naming latencies for the negative words for both conditions relative to the
control group. In the second test session, after the anxiety patients received CBT, there were no
differences in color-naming latencies for negative words between CBT treated anxious patients
and the controls. One additional study by Mathews, Mogg, Kentish, & Eysenck (1995) observed
the effects of CBT on anxiety patients using the modified Stroop task, an attentional search task,
and a word completion task. Prior to treatment, the anxious participants displayed longer colornaming latencies for threatening words and displayed longer latencies to locate targets among
threatening distractors relative to non-threatening distractors when compared to controls.
However, no differences were found between group, priming, and word valance on the word
completion task, which is inconsistent with previous findings. After CBT treatment, the negative
interpretation bias for the anxious individuals was reduced and no longer significantly differed
from the controls on the Stroop task and the attentional search task (Mathews et al., 1995).
Cognitive behavioral therapy has also been used to reverse the cognitive bias observed in
depressed individuals. In a study by Segal & Gemar (1997) depressed patients were tested on a
10

primed modified Stroop Task before and after having received CBT. The Stroop Task target
words were primed by emotional phrases that varied in their degree of self-descriptiveness. The
primes were presented in black and white before the to-be-named negative self-descriptive or
negative non-self-descriptive word appeared. Segal and Germar (1997) found that before CBT
treatment, depressed patients displayed longest response latencies when both the prime and
target word were negatively self-descriptive. Following CBT treatment, patients that showed the
most recovery also showed greater improvement for color-naming interference for the negative
self-descriptive targets primed by the negative self-descriptive phrases when compared with the
negative non-self-descriptive phrases. The patients that still had high levels of depression
following treatment showed higher levels of negative interference in the same prime/target
condition, resembling the non-treated depressed patients (Segal & Germar, 1997). Similar
reversal patterns are observed for the cognitive bias in anxiety and depression using
pharmacotherapies
Using pharmacotherapy to reverse the cognitive bias seen in anxiety, Weinstein & Nutt
(1995) reported that before treatment, anxious individuals displayed longer response latencies for
emotional words on the modified Stroop task as compared to a recovered anxious, depressed and
control group. After treatment with SSRIs (serotonin selective reuptake inhibitors),
antidepressants also known to have anxiolytic properties, the previously anxious patients no
longer significantly differed from the control group; suggesting that cognitive bias is responsive
to pharmacological treatments (Weinstein & Nutt, 1995). In a similar study, Mogg, Baldwin,
Brodrick, & Bradley (2004) observed a reversal of symptoms of cognitive bias in anxiety with
SSRI treatment using the homophone task. After administration of SSRIs, anxious individuals
displayed not only lower levels of anxiety, but also lower levels of negative interpretive biasing
11

on the task. Further, the cognitive bias processes decreased as a function of improvement in the
treatment of anxiety; the more efficacious the treatment, the fewer negative interpretations
presented (Mogg et al., 2004). Though these findings seem promising, not all of the drug classes
produced similar results.
Golombok et al. (1991) was unable to observe a reversal of cognitive bias on the
modified Stroop task upon administration of the benzodiazepine anxiolytics. Although the
benzodiazepines did appear to reduce anxiety and create an overall slowing of latencies for the
task, there were no improvements in the negative interpretation biases. Golombok et al. (1991)
concluded that the benzodiazepines only ameliorate an anxious mood, not the cognitive
disturbances associated with anxiety. In a similar study, Stewart, Westra, Thompson, & Conrad
(2000) wanted to observe the effects of naturalistic benzodiazepine use (i.e. taken on an “as
needed basis”) on cognitive bias within a variety of anxiety disorders (e.g., generalized anxiety
disorder, post traumatic stress disorder) to assess possible tolerance effects on the cognitive
impairments produced by benzodiazepines and also to test the theory that benzodiazepines
increase attention to threat-related stimuli. Consistent with the results from Golombok et al.
(1991), individuals currently taking benzodiazepines did not reveal any improvements in the
negative interpretation bias as compared to the medication nonusers. Further, the
benzodiazepine users displayed greater attention to threat cues than the medication nonusers
suggesting that the benzodiazepines do increase attention to threat-related stimuli (Stewart et al.,
2000).
A study by Harmer, O’Sullivan, Favaron, Massey-Chase, Ayres, and Reinecke et al.
(2009) examined the effects of a single dose of reboxetine, a norepinephrine selective reuptake
inhibitor, or a placebo on negative affective bias in depressed individuals and healthy controls.
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Three hours after drug administration all participants were tested using a facial expression
recognition task and an emotional categorization and memory task. The administration of
reboxetine did not produce changes in mood or anxiety in either patients or controls. The facial
expression recognition task which required individuals to identify the correct emotional
expression (e.g., happiness, surprise, sadness, fear, and anger) revealed that depressed
individuals were less accurate in recognizing facial expressions of happiness and surprise
compared to the controls, indicative of cognitive bias. This effect was reversed by reboxetine
which increased the perception of happy facial expressions in depressed individuals. In a
separate task, depressed individuals displayed longer response latencies for positive selfreferential characteristics relative to negative self-referential characteristics compared to
controls, indicative of a negative bias when judging one’s personality. This effect was reversed
by reboxetine which shortened response latencies for positive self-referential characteristics in
depressed individuals. Further, depressed individuals had the worst recall of personality
characteristics, especially those that were positive on the emotional memory task. This effect was
reversed by reboxetine which improved recall of the positive self-referential characteristics
(Harmer et al., 2009).
It is interesting to note that the phenomenon of cognitive bias in humans has also been
examined in non-human animals such as rhesus macaques, dogs, rats, and avians subjected to
various stressors (Bateson & Matheson, 2007 Bethell, Semple, Holmes, & MacLarnon, 2007;
Brilot, Normandale, Parkin, & Bateson, 2009; Burman, Parker, Paul, & Mendl, 2009; Harding,
Paul, & Mendl, 2004; Matheson, Asher, & Bateson, 2008; for review see Mendl, Burman,
Parker, & Paul, 2004). For example, Bateson & Matheson (2007), trained European Starlings on
a go/no-go task to differentiate between two visual stimuli, colored cardboard lids, representing
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appetitive or aversive outcomes (e.g., white lids concealed a palatable mealworm; black lids
concealed an aversive tasting mealworm). Prior to testing, the housing conditions were
manipulated from an enriched to an impoverished environment, (inducing a more pessimistic
state) or from an impoverished to an enriched environment (inducing a less optimistic state). At
testing, starlings were exposed to ambiguous colored lids, intermediate shades of grey between
black and white. Starlings that were switched from an enriched to an impoverished environment
were less likely to flip the intermediate grey lids than those that were switched from an
impoverished to an enriched environment (i.e., more pessimistic behavior after a decline in
environment). Matheson et al., 2008, utilized a similar paradigm to assess the effects of chronic
enriched or standard housing environments on cognitive bias. In this study, starlings were
trained to differentiate two temporal stimuli (e.g., 2 versus 10 second light stimuli) for an instant
or delayed food reward and at test were exposed to a range of ambiguous temporal durations
within the 2 to 10 second range. Compared to starlings housed in an enriched environment that
were more likely to classify the ambiguous stimuli as being associated with an instant food
reward, those in standard housing were less likely to do so. The behavior of starlings housed in
standard cages reflects less optimism associated with depression-like states.
More recent studies of cognitive bias have examined behavioral responses to
ecologically-relevant stimuli that are likely to produce similar approach-avoidant responses, but
without extensive training. Brilot et al., 2009, used variations of eyespots, which are naturally
aversive to many avian species, in conjunction with neutral or threatening, anxiety producing,
calls to assess cognitive biases in starlings. Immediately after playing a particular call they
recorded the starlings’ behavior in front of either eyespots, ambiguous eyespots, or no eyespots.
Although there was no interaction between the anxiety states induced by different calls and
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responses to the various eyespot stimuli, the eyespots did reveal to be generally aversive to
starlings and therefore an accurate assessment of anxiety and approach behavior.
To measure approach-avoidant behaviors in domestic fowl chicks, Salmeto et al. (in
preparation) used a straight-alley maze, a paradigm used to quantify chick social reinstatement
(Marin, Freytes,, Guzman, & Jones, 2001) with start and goal latencies as the dependent
measure. Various stimulus cues were located at the goal which served as the approach-avoidant
manipulation. The stimulus cues were a silhouette of a conspecific chick (or mirror), a silhouette
of a horned owl, a natural predator to the chick, and three intermediate ambiguous silhouettes
with varying degrees of characteristics between the two (e.g., 75c:25o, 50c:50o, 25c:75o). In
Experiment 1, non-stressed chicks displayed start latencies that were unaffected by the various
stimulus cues, whereas goal latencies were longer under cues with greater owl silhouette
characteristics.
These results reveal that the range of stimulus cues produce the necessary
approach/avoidant behavior to examine cognitive bias under anxiety- and depressive-like states.
One interesting finding was that chicks displayed longer goal latencies under the Chick stimulus
cue than for the mirror cue in the pre-test session. Therefore, the second experiment replaced the
Chick stimulus for the mirror to promote more life-like characteristics than that of a still image to
allow for the most effect approach behavior.
Experiment 2 utilized the same procedure with the introduction of an initial isolation
manipulation to induce either an anxiety-like state (5-min isolation) or a depression-like state
(60-min isolation). In the social condition, start latencies were unaffected by the various
stimulus cues, which is consistent with Experiment 1 results. In the anxiety-like condition, start
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latencies were significantly longer under the stimulus cues with greater aversive characteristics
(e.g., 50c:50o, 25c:75o, and Owl) relative to the social condition. These results reflect the
cognitive bias of more pessimism, which is an increased avoidant behavior to ambiguous
aversive stimuli. In the depression-like condition, start latencies were significantly longer under
the stimuli with greater aversive characteristics, as well as greater appetitive characteristics (e.g.,
Chick and 75c:25o) relative to the social condition. These results reflect the cognitive bias of
more pessimism, as well as less optimism, which is a decreased approach behavior to ambiguous
appetitive stimuli.
However, the goal latencies did not produce such clear results. Relative to the social
condition, goal latencies in the anxiety-like and depression-like conditions were significantly
longer under the 50c:50o and the Owl stimulus cues (i.e., more pessimism), but not the 25c:75o
stimulus cue. In addition, goal latencies in the depression-like conditions were significantly
longer in the Chick cue (i.e., less optimism), but not in the 75c:25o stimulus cue. These results
may be due to a ceiling effect imposed by the 5-min test session criteria as many of the chicks
did approach the cues to varying degrees but did not reach the goal line.
Collectively, these observations reveal that a runway test to ambiguous appetitive and
aversive cues can assess both types of cognitive biases within a single paradigm. In addition, the
chick model produced results that are consistent with how cognitive bias presents in the human
clinical literature, wherein more pessimism is present in the anxiety-like state and both more
pessimism and less optimism are present in the depression-like state.
Animal models are evaluated on their validity and one way to strengthen validity is to
increase the number of homologies between the human clinical disorder and the model. Given
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that the chick anxiety-depression continuum model is able to show cognitive bias and given that
humans show a reversal of cognitive bias subsequent to treatment, it should follow that cognitive
bias can be reversed in the chick model. Therefore this research will attempt to reverse these
forms of cognitive biases in the two clinical states modeled by the chick anxiety-depression
continuum simulation with pharmacological probes. These findings would provide a further
validation of the chick anxiety-depression continuum model as a neuropsychiatric simulation.
Methods
Subjects and Housing Characteristics
Cockerels (Gallus gallus; W36; Cal-Maine Foods, Inc., Mendenhall, Mississippi, USA)
were received 1-day post hatch and housed in 34 × 57 × 40 cm stainless steel cages with 12–13
chicks per cage. Chicks were removed and briefly handled daily to minimize experimenterrelated stress. Food (Purina Start and Grow, St Louis, Missouri, USA) and water was available
ad libitum through one quart gravity-fed feeders (Murray MacMurray; Model 4BGFJ) and
waterers (Murray MacMurray; Model 4YQW0). Room temperature was maintained at 29 ± 1 °C
and overhead illumination was maintained on a 12-h light-dark cycle.
Apparatus
Straight alley maze
The apparatus consisted of a 50 x 30 x 10 cm arena made of opaque high-density
polyethylene material that contained a straight alley maze adjacent to a holding arena (see Fig.
1). The straight alley maze consisted of a 10 x 10 x 10 cm start box with a guillotine door that
opens up to a 40 x 10 x 10 cm runway with either an 8 x 10 cm mirror or various 8 x 10 cm
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stimulus cues placed at its end (detailed below). The runway contained markings in 5 cm units
that permitted a measure of distance traveled. A 40 x 20 x 10 cm holding arena housed 12
conspecifics throughout the test session and permitted the testing of chicks under non-isolated
treatment conditions. These conspecifics remained out of view during maze testing. However,
once chicks reach the goal, full view of the arena was permitted through a 20 x 10 cm clear
Plexiglas wall. Pine bedding was placed throughout the arena floor and food and water was
available ad libitum in 200 ml stainless steel cups. A pilot study demonstrated that
approximately 90% of non-isolated chicks exited the start box within 30 sec and reached the goal
within 60 sec of a 5 min test period under the mirror test condition.
Morphed Stimulus Conditions
Morpheus Photo Morpher v3.01 Professional for Mac (Morpheus Software, LLC) was
used to produce ‘morphed’ images that blended elements of a chick and a horned owl silhouette.
To determine whether the owl silhouette served as an aversive cue, a second pilot study was
conducted using two test sessions separated by one day. The first test was conducted using the
mirror cue and replicated the findings of the first pilot study. The second test utilized the owl
silhouette cue and demonstrated that approximately 85% of non-isolated chicks exited the start
box within 30 sec and approximately 80% failed to reach the goal within the 5 min test period.
From the chick and owl silhouette cues, software mapped a series of approximately 200
dots onto each photos to match the location of the dots between the images. This allowed for 100
morphed frames linking the start (chick) and end (owl) photos. Within this series two key frames
were defined: 75% chick and 25% owl, and 25% chick and 75% owl were used (75c:25o and
25c:75o). The pixellated edges of the images were smoothed out and the images were adjusted so
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that they were all approximately the same size and fit on an 8 x 10 cm stimulus card. The images
were saved as jpeg files, printed and placed behind a clear glass plate during testing (see Fig. 2).
Isolation Apparatus
A six-unit test apparatus containing Plexiglas viewing chambers (25x 25x 22 cm) situated
in sound-attenuating enclosures was used for behavioral data collection. The units were
illuminated using 25W light bulbs and ventilated by an 8-cm diameter rotary fan (Model FP108AXS1; Rodale, Great River, New York, USA). Miniature video cameras (Model PC60XP;
SuperCircuit, Liberty Hill, Texas, USA) mounted at floor level in the corner of the enclosures
and routed through a multiplexer (Model PC47MC; SuperCircuit) allowed for animal
observation. Distress vocalizations were collected via microphones [Model 3-675-001
(modified); Lafayette Instruments, Lafayette, Indiana, USA] mounted on the rear wall of the
Plexiglas chamber, routed through sound-activating relays (Model 630400A; Lafayette
Instruments; settings: 60–75% sensitivity, 0.10-s delay) and collected a USB interface via
custom-designed software
Experiment 1
Procedure
Experiment 1 was conducted to ensure that drug treatments, clonidine and imipramine, do
not substantially influence cognitive decision making to natural and ambiguous appetitive and
aversive stimulus cues in the social treatment condition. In this experiment, chicks were tested
across ages 4-6 days post hatch. In the first trial, at age 4 days post hatch, 12 cagemate
conspecifics were placed into the holding arena and individually tested in the maze under the
mirror cue condition. Each chick was placed into the start box for 15 sec after which the
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guillotine door was raised. Dependent measures were start and goal latencies and farthest
distance traveled. Start latency was defined as the time it takes to step completely outside the
start box. Goal latency was defined as the time to cross a defined mark located 10 cm away from
the mirror or stimulus cue. Because all test sessions were terminated at 5 min, the farthest
distance traveled (cm) from the start box was measured to account for possible differences
between chicks that complete the straight alley maze and those that did not. Chicks were placed
back into the holding arena until all were tested. Group assignment for Trial 2 was based on goal
latencies from this test session.
The second trial was conducted at either 5 or 6 days post hatch and consisted of three
social groups that were administered either 0.15mg/kg clonidine (tested for 5-min), 15mg/kg
Imipramine (tested for 60-min), or a physiological saline (tested for 60-min). All chicks were
injected with drug probes 15-min prior to apparatus testing and were tested with two cagemate
conspecifics. Following apparatus testing, chicks were transported from the isolation apparatus
in a 2 quart opaque plastic container and tested immediately in the maze under four stimulus cue
conditions: mirror, 25c:75o morph, 75c:25o morph: and 0c:100o (owl silhouette), based on the
goal latencies from Trial 1. To assess a baseline for each stimulus cue, a no-isolation test control
group was administered saline and tested immediately within the maze. In addition, these chicks
remained in the arena throughout the test session. Dependent measures for the maze are as
described above. Chicks were returned to their home cage after testing.
Statistical Analysis
To assess for significant isolation-group differences and significant pharmacological
effects on distress vocalizations in the anxiety-like and depression-like phases, all DVocs were
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transformed into a rate/min function. A 1-way ANOVA was conducted on the anxiety-like
phase (i.e., first 5-min/5) and on the depression-like phase (i.e., 30-60min/30). Post-hoc analyses
were conducted using Fisher’s least significant difference tests.
To assess for significant isolation-group differences and significant pharmacological
effects on the cognitive biases seen under each individual stimulus cue, four 3 x 5 MANOVAs
were conducted with mean start latency, mean goal latency, and mean distance traveled as the
dependent variables. A priori planning to assess group differences across each stimulus cue
individually set the MANOVA p-value at p > 0.0125. Given the significance of the MANOVA, a
1-way ANOVA was conducted upon each dependent variable. Given the significance of the
ANOVA, a Tukey’s Post Hoc analysis was conducted to compare group means of the five drug
treatment conditions. Chicks that were clearly sedated within the maze were discarded from the
analysis. Sedation was operationally defined as either falling asleep or appearing drowsy with
eyes closing.
Results
Distress Vocalizations
The effects of various drug treatments on DVocs rates for chicks tested socially (i.e., with
two cagemate conspecifics) in the anxiety-like and depression-like phases are presented in Figure
3, respectively. Chicks in the vehicle group (tested for 60-min) displayed relatively high DVoc
rates in the first 5-min, indicative of an anxiety-like (panic-like) state; then, DVoc rates declined
by approximately 50% of the initial response rate during the final 30-min of the test session (i.e.,
30-60 min), indicative of a depression-like state (i.e., behavioral despair). Chicks in both the
anxiety-clonidine and depression-imipramine groups displayed DVoc rates that were
21

significantly attenuated compared to the vehicle group in the anxiety-like phase. In addition,
chicks in the depression-imipramine group displayed DVoc rates that were significantly higher
compared to the vehicle group in the depression-like phase (i.e., 30-60 min) of isolation.
Consistent with these observations, a one-way ANOVA revealed a significant main effect
for Treatment [F(2,95) = 12.46, p < 0.001]. Fisher’s PLSD post hoc analyses revealed that the
anxiety-clonidine and the depression- imipramine groups displayed significantly lower mean
DVoc rates compared to the vehicle group in the anxiety-like phase (ps < 0.001). In addition, the
depression-imipramine group displayed significantly higher mean DVoc rates in the depressionlike phase (p < 0.001).
Mirror Stimulus Cue
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the mirror stimulus cue are presented in Figure 4 panels A, B, and
C, respectively. In the vehicle no-test group, mean start latency was relatively short (e.g., chicks
left the start box in approximately 40-sec), and goal latency was relatively long (e.g., chicks
reached the goal in approximately 2 ½-min; half the allotted time). Mean distance traveled for
the vehicle no-test group was approximately 27 cm, indicating that most chicks either completed
the maze or approached the stimulus cue. Mean start and goal latencies and mean distance
traveled for the vehicle isolation-test group did not differ compared to the vehicle no-test group
(ps = n.s.). Mean start latency for the anxiety-clonidine group was somewhat shorter compared
to the vehicle isolation-test group; however, mean goal latency and mean distance traveled for
these groups were not. Mean start and goal latencies and mean distance traveled for the
depression-imipramine group did not differ from the two vehicle conditions (ps = n.s.).
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Consistent with these observations, a one-way MANOVA failed to reveal a significant
multivariate main effect for treatment, Wilks’ λ = 0.531, F(9,75.60) = 2.49, p = 0.015, where p <
0.0125 is considered significant, partial eta squared = 0.190. Power to detect the effect was
0.808. Given the absence of a significant MANOVA, no further analyses were conducted on
these data.
75c:25o (Ambiguous Chick Stimulus Cue)
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of
Figure 5, respectively. In the vehicle no-test group, mean start latency was relatively short (e.g.,
chicks left the start box approximately under a minute), and goal latency was relatively long
(e.g., chicks reached the goal in approximately 3 ½-min; more than half of the allotted time).
Mean distance traveled for the vehicle no-test group was approximately 23 cm, indicating that
most chicks either completed the maze or approached the stimulus cue. In general, mean goal
latency and mean distance traveled were unaffected by the various treatment conditions (ps =
n.s.), see panels B and C of Figure 5. However, mean start latency for the vehicle isolation-test
group was longer compared to the vehicle no-test group and this effect was reversed by the
depression-imipramine group and appeared to be reversed by the anxiety-clonidine group.
Consistent with these observations, a one-way MANOVA approached a significant
multivariate main effect for treatment, Wilks’ λ = 0.480, F(9, 65.86) = 2.58, p < 0.013 where p <
0.0125 is considered significant, partial eta squared = 0.217. Power to detect the effect was
0.815. Given the marginal significance of the overall test, the univariate main effects were
examined. Significant univariate main effects for treatment were obtained for mean start latency
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F(3,29) = 5.62, p < 0.005. Tukey’s HSD post hoc comparisons revealed significantly longer
mean start latency for the vehicle isolation-test group compared to the vehicle no-test group (p <
0.01). And, the depression-imipramine group revealed a mean start latency that was significantly
shorter compared to the vehicle isolation-test group (p < 0.01) whereas, the anxiety-clonidine
group was marginally significantly shorter compared to the vehicle isolation-test group (p =
0.055).
25c:75o (Ambiguous Owl Stimulus Cue)
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of
Figure 6, respectively. In the vehicle no-test group, mean start latency was very short (e.g.,
chicks left the start box approximately under 10-sec), and goal latency was relatively long (e.g.,
chicks reached the goal in approximately 4-min; approaching cut off criteria). Mean distance
traveled for the vehicle no-test group was approximately 23 cm, indicating that most chicks
either completed the maze or approached the stimulus cue. Mean start latency for the vehicle
isolation-test group was longer compared to the vehicle no-test and this effect was reversed by
the depression-imipramine group and the anxiety-clonidine group. In general, mean goal
latencies were unaffected by the various treatment conditions (ps = n.s.), see panel B Figure 6.
Mean distance traveled for the vehicle isolation-test group was shorter compared to the vehicle
no-test group and this effect was reversed by the depression-imipramine group.
Consistent with these observations, a one-way MANOVA revealed a significant
multivariate main effect for treatment, Wilks’ λ = 0.400, F(9, 70.73) = 3.59, p < 0.001, where p <
0.0125 is considered significant, partial eta squared = 0.263. Power to detect the effect was
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0.938. Given the significance of the overall test, the univariate main effects were examined.
Significant univariate main effects for treatment were obtained for mean start latency F(3,31) =
13.67, p < 0.001, and for mean distance traveled F(3,31) = 5.97, p < 0.005. Tukey’s HSD post
hoc comparisons revealed significantly longer mean start latency for the vehicle isolation-test
group compared to the vehicle no-test group (p < 0.001). The depression-imipramine and
anxiety-clonidine groups revealed a mean start latency that was significantly shorter compared to
the vehicle isolation-test group (ps < 0.01). Further, mean distance traveled for the vehicle
isolation-test group was significantly shorter compared to the vehicle-test group and the
depression-imipramine group was significantly longer compared to the vehicle isolation-test
group (ps < 0.01).
0c:100o (Owl Stimulus Cue)
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the 0c:100o stimulus cue are presented in panels A, B, and C of
Figure 7, respectively. In the vehicle no-test group, mean start latencies were relatively short
(e.g., chicks left the start box in under a minute); whereas, mean goal latencies were relatively
long (e.g., chicks reached the goal in approximately 5-min; the cutoff criterion). Mean distance
traveled for the vehicle no-test group was approximately 20 cm, indicating that although most
chicks approached the stimulus cue, they did not reach the goal. Mean start and goal latencies
and mean distance traveled for the vehicle-test, the anxiety-clonidine, and the depressionimipramine were not significantly different compared to the vehicle no-test group.
Consistent with these observations, a one-way MANOVA failed to reveal a significant
multivariate main effect for treatment, Wilks’ λ = 0.807, F(9,65.86) = 0.68, p < 0.73, where p <
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0.0125 is considered significant partial eta squared = 0.069. Power to detect the effect was 0.244.
No further analyses were conducted on these data.
Discussion
Experiment 1 was conducted to determine if the drug probes, clonidine and imipramine,
would have an effect on runway performance independent of a stress manipulation. In previous
experiments, chicks tested socially (i.e., with two cagemate conspecifics) exhibited a low rate of
DVocs during a 60-min test session; that rate of DVocs was significantly increased compared to
the socially tested condition when the chicks were tested in isolation (Sufka et al., 2006). Given
these findings, we believed the test apparatus would not induce a significant amount of stress to
socially tested chicks. Therefore, three social groups administered clonidine, imipramine, or a
vehicle which consisted of a physiological saline, were tested within the isolation apparatus
which was immediately followed with maze testing. Since all treatment groups should have
performed similarly, a vehicle no-isolation test control was included to gather baseline runway
data for each stimulus cue. Distress vocalizations served as the dependent behavioral measure.
And, start and goal latency and distance traveled served as the dependent measures for the maze.
Several unexpected finding arose and are discussed below.
Distress Vocalizations
Although it was not predicted, the patterns of DVocs observed in the anxiety-like and
depression-like phases were consistent with previous findings (Sufka et. al., 2006). A significant
difference in DVocs rates presented between drug-treatment groups within socially tested chicks.
In the anxiety-like phase, DVocs for the clonidine and imipramine groups were significantly
attenuated compared to the vehicle group. And, in the depression-like phase, DVocs for the
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imipramine group were significantly higher compared to the vehicle group. Because differences
exist in DVoc rates between drug groups for socially treated chicks, it appears that the chicks are
experiencing some measurable amount of stress even within the social isolation manipulation.
Several factors could have collectively produced the stress experienced by the chicks,
some of which include: experimenter stress, the injection procedure, novelty to the testing
apparatus (Feltenstein, Ford, Freeman, & Sufka, 2002), and flock reduction. Chicks are housed
12 to a cage and any amount of flock reduction may have facilitated the observed stress which
was also attenuated with the drug probes administered. Testing drug probes in socially tested
chicks has not been examined. This is an avenue of research that should be further explored to
gain a better understanding of the level of stress induced upon the chicks and prevented by the
drug probes administered.
Straight Alley Maze
Under the mirror and 0c:100o (owl) stimulus cues no observable behavioral differences
existed in runway performance between the drug treatment groups; however, significant runway
differences did present under the ambiguous stimulus cues. Under the75c:25o (ambiguous chick
cue), significant runway differences did present under mean start latency. The vehicle isolationtest group presented significantly longer mean start latencies compared to the vehicle no-test
group. Although this finding was unexpected, it agrees with the DVoc patterns observed for the
vehicle isolation group (tested for 60-min), which are similar to the stress responses exhibited by
isolated chicks, although to a lesser degree. Therefore, it follows that the difference between
vehicle groups was due to the vehicle isolation-test group exhibiting less optimistic behavior
(i.e., less approach behavior towards ambiguous appetitive cues) under a depressive-like state.
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In addition, the less optimism observed under the depression-like state was reversed by
imipramine in the depression-imipramine group which is also consistent with the significant
reversal of DVoc rates in the depression-like phase.
A similar pattern was revealed under the 25c:75o (ambiguous owl cue) for mean start
latency and mean distance traveled. The vehicle isolation-test group presented significantly
longer mean start latencies compared to the vehicle no-test group. Again, this finding was
unexpected, but it agrees with the DVoc patterns observed for the vehicle isolation group (tested
for 60-min), which are similar to the stress responses exhibited by isolated chicks, although to a
lesser degree. Therefore, it follows that the difference between vehicle groups was due to the
vehicle isolation-test group exhibiting more pessimistic behavior (i.e., less approach behavior
towards ambiguous aversive cues) under a depressive-like state. In addition, the more pessimism
observed under the depression-like state was reversed by imipramine in the depressionimipramine group which is also consistent with the significant reversal of DVoc rates in the
depression-like phase. The vehicle isolation-test group also presented significantly shorter mean
distance traveled compared to the vehicle no-test group. This finding was unexpected given it
was a novel measure, but it agrees with the both the DVoc patterns observed for the vehicle
isolation group (tested for 60-min) and the cognitive bias of more pessimism observed.
Therefore, it follows that the difference in mean distance traveled between vehicle groups was
due to the vehicle no-test group exhibiting more pessimistic behavior (i.e., less approach
behavior towards ambiguous aversive cues) under a depressive-like state. In addition, the more
pessimism observed under the depression-like state was reversed by imipramine in the
depression-imipramine group which is indicated by a longer mean distance traveled. This finding
is also consistent with the significant reversal of DVoc rates in the depression-like phase and the
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significant reversal of the cognitive bias of more pessimism under an ambiguous aversive cue.
Given the unexpected finding of differences within the vehicle groups, the vehicle no-test group
was chosen to be the main control group for Experiment 2.
One additional finding was that for the anxiety-clonidine group, start latencies under the
mirror, 75c:25o, and 25c:75o stimulus cues were significantly shorter compared to the vehicle
isolation-test group and mean distance traveled under the 25c:75o stimulus cue was significantly
shorter compared to the vehicle isolation-test group. However we did not include a vehicle-5min test condition, because such differences were not expected. Therefore, a fifth treatment
group was added to the experiment; a vehicle 5-min isolation group to use as a control for the
anxiety-clonidine group. However, an alternative explanation for these observed effects could be
that clonidine at a dose of 0.15mg/kg produced observable sedative effects within the runway.
Chicks that were either sleeping or appeared drowsy within the maze were discarded from the
analysis. We believe that the sedative effects observed could be from clonidine acting in a
context dependent manner. More specifically, when given clonidine in a stressful environment it
will act as an anxiolytic, but given in a minimally stressful environment it may produce sedative
effects. Clonidine’s behavioral effects beyond a 5-min isolation period or within a different
testing apparatus have not been examined in this paradigm. Therefore, we decreased the dose of
clonidine given in Experiment 2 to 0.10mg/kg to lessen the likelihood of sedation.
Experiment 2
Procedure
Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a
depression-like phase and to test whether those cognitive biases could be pharmacologically
reversed. More specifically, testing whether clonidine, an anxiolytic, could reverse the cognitive
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bias of more pessimism (i.e., less approach behavior towards ambiguous aversive cues) observed
under the anxiety-like phase. And also, testing whether imipramine, an antidepressant with
anxiolytic effects, could reverse not only the cognitive bias of more pessimism (i.e., less
approach behavior towards ambiguous aversive cues) observed under the anxiety-like phase, but
also the cognitive bias of less optimism (i.e., less approach behavior towards ambiguous
appetitive cues) observed under the depression-like phase. Experiment 2 was conducted
following the same procedures as Experiment 1 with three exceptions: 1) a new treatment
condition, a vehicle 5-min isolation group to use as a control for the anxiety-clonidine group; 2)
lowering the dose of clonidine from 0.15mg/kg to 0.10mg/kg to lessen the likelihood of sedation
within the runway; and 3) the induction of the isolation produce within the testing apparatus. All
dependent measures and statistical analyses remained the same.
Results
Distress Vocalizations
The effects of various drug treatments on DVocs rates for chicks tested in the anxiety-like
and depression-like phases are presented in Figure 8, respectively. Chicks in the vehicle group
displayed relatively high DVoc rates in the first 5-min, indicative of an anxiety-like (panic-like)
state; then, DVoc rates declined by approximately 50% of the initial response rate during the
final 30-min of the test session (i.e., 30-60 min); indicative of a depression-like state (i.e.,
behavioral despair). Chicks in both the anxiety-clonidine and depression-imipramine groups
displayed DVoc rates that were attenuated compared to the vehicle group in the anxiety-like
phase (i.e., first 5-min) of isolation. In addition, chicks in the depression-imipramine group
displayed DVoc rates that were higher compared to the vehicle group in the depression-like
phase (i.e., 30-60 min) of isolation.
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Consistent with these observations, a one-way ANOVA conducted on the anxiety-like
phase revealed a significant main effect for Treatment [F(2,195) =42.43, p = 0.001]. Fisher’s
LSD post hoc analyses revealed that the anxiety-clonidine and depression-imipramine groups
displayed significantly lower DVoc rates compared to the vehicle group in the anxiety-like phase
(ps = 0.001). A one-way ANOVA conducted on the depression-like phase revealed a significant
main effect for Treatment [F(1,100)=18.30, p = 0.001]. Fisher’s LSD post hoc analyses revealed
that the depression-imipramine group displayed significantly higher DVoc rates compared to the
vehicle group in the depression-like phase (p= 0.001)
Mirror Stimulus Cue
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the mirror stimulus cue are presented in panels A, B and C of
Figure 9, respectively. In the vehicle no-test group, mean start and goal latencies were relatively
short (e.g., chicks left the start box in approximately 10-sec and reached the goal in under 40sec). Mean distance traveled for the vehicle no-test group was 30 cm, indicating the runway was
completed. Mean start and goal latencies and mean distance traveled for the vehicle-anxiety and
anxiety-clonidine groups did not differ from the vehicle no-test group or compared to each other
(ps = n.s.).
Mean start latency for the vehicle-depression group was longer compared to the vehicle
no-test group and this effect was reversed by the depression-imipramine group. Mean goal
latency for the vehicle-depression group was longer compared to the vehicle no-test group, and
this effect was somewhat reversed by the depression-imipramine group. Mean distance traveled
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for the vehicle-depression group was somewhat shorter compared to the vehicle no-test group
and this effect was somewhat reversed by the depression-imipramine group.
Consistent with these observations, a one-way MANOVA revealed a significant
multivariate main effect for treatment, Wilks’ λ = 0.540, F(12, 156.39) = 3.42, p < 0.001, where
p < 0.0125 is considered significant, partial eta squared = 0.186. Power to detect the effect was
0.988. Given the significance of the overall test, the univariate main effects were examined.
Significant univariate main effects for treatment were obtained for mean start latency F(4,61) =
7.91, p < 0.001; mean goal latency F(4,61) = 6.37, p < 0.001; and, mean distance traveled,
F(4,61) = 2.860, p < 0.05.
Tukey’s HSD post hoc comparisons revealed significantly longer mean start latency for
the vehicle-depression group compared to the vehicle no-test group and a shorter mean start
latency for the depression-imipramine group compared to the vehicle-depression group (ps <
0.005). Mean goal latency for the vehicle-depression group was significantly longer compared
to the vehicle no-test group (p <0.001), and the depression-imipramine group revealed a
marginally shorter mean goal latency compared to the vehicle-depression group (p = .065).
Mean distance traveled for the vehicle-depression group was marginally shorter compared to the
vehicle no-test group (p = 0.73), and the depression-imipramine group revealed a marginally
shorter mean distance traveled compared to the vehicle-depression group (p = .083)
75c:25o (Ambiguous Chick Stimulus Cue)
The effects of various drug treatment conditions on mean start and goal latencies and
mean distance traveled under the 75c:25o stimulus cue are presented in panels A, B, and C of
Figure 10, respectively. In the vehicle no-test group, mean start latencies were relatively short
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(e.g., chicks left the start box in under a minute); whereas, mean goal latencies were relatively
long (e.g., chicks reached the goal in approximately 4-min). The mean distance traveled for the
vehicle no-test group was 25 cm, indicating that most chicks either completed the maze or
approached the stimulus cue. Mean start and goal latencies and mean distance traveled for the
vehicle-anxiety group did not differ from the vehicle no-test group or from the anxiety-clonidine
group (ps = n.s.). Mean start latency for the anxiety-clonidine group was somewhat longer
compared to the vehicle no-test group, however mean goal latency and mean distance traveled
did not differ from the vehicle no-test group (ps = n.s.).
Mean start latency for the vehicle-depression group was longer compared to the vehicle
no-test group and this effect was reversed by the depression-imipramine group. Mean goal
latency for the vehicle-depression group did not differ from the vehicle no-test group and mean
goal latency for the depression-imipramine group did not differ from the vehicle-depression
group (ps = n.s). Mean distance traveled for the vehicle-depression group was shorter than the
vehicle no-test group and this effect was reversed by the depression-imipramine group.
Consistent with these observations, a one-way MANOVA revealed a significant
multivariate main effect for treatment, Wilks’ λ = 0.592, F(12,145.81) = 2.66, p < 0.005, where p
< 0.0125 is considered significant, partial eta squared = 0.160. Power to detect the effect was
0.951. Given the significance of the overall test, the univariate main effects were examined.
Significant univariate main effects for treatment were obtained for mean start latency F(4,57) =
7.43, p < 0.001, and mean distance traveled F(4,57) = 7.26, p < 0.001.
Tukey’s HSD post hoc comparisons revealed a marginally significantly longer mean
start latency for the anxiety-clonidine group compared to the vehicle no-test group (ps < 0.072).
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In addition, the post hoc comparisons revealed significantly longer mean start latency for the
vehicle-depression group compared to the vehicle no-test group and a shorter mean start latency
for the depression-imipramine group compared to the vehicle-depression group (ps < 0.001).
Mean distance traveled for the vehicle-depression group was significantly shorter compared to
the vehicle no-test group, and the mean distance traveled for the imipramine-depression group
was significantly longer compared to the vehicle-depression group (ps < 0.005).
25c:75o (Ambiguous Owl Stimulus Cue)
The effects of various drug treatment conditions on start and goal latencies and distance
traveled under the 25c:75o stimulus cue are presented in panels A, B, and C of Figure 11,
respectively. In the vehicle no-test group, mean start latencies were relatively short (e.g., chicks
left the start box in under a minute); whereas, mean goal latencies were relatively long (e.g.,
chicks reached the goal in approximately 5-min; the cutoff criterion). The mean distance
traveled for the vehicle no-test group was approximately 21 cm, indicating that although most
chicks approached the stimulus cue, they did not reach the goal. Mean start latency for the
vehicle-anxiety group was somewhat longer compared to the vehicle no-test group, however
mean goal latency and mean distance traveled did not differ from the vehicle no-test group (ps =
n.s). Mean start and goal latencies and mean distance traveled for the anxiety-clonidine group did
not differ from the vehicle no-test group or from the vehicle-anxiety group (ps = n.s.).
Mean start latency for the vehicle-depression group was longer compared to the vehicle
no-test group and this effect was reversed by the depression-imipramine group. Mean goal
latency for the vehicle-depression group did not differ from the vehicle no-test group and mean
goal latency for the depression-imipramine group did not differ from the vehicle-depression
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group (ps = n.s). Mean distance traveled for the vehicle-depression group was somewhat shorter
compared to the vehicle no-test group and this effect was somewhat reversed by the depressionimipramine group.
Consistent with these observations, a one-way MANOVA revealed a significant
multivariate main effect for treatment, Wilks’ λ = 0.560, F(12,135.23) = 2.76, p < 0.005, where p
< 0.0125 is considered significant, partial eta squared = 0.176. Power to detect the effect was
0.957. Given the significance of the overall test, the univariate main effects were examined.
Significant univariate main effects for treatment were obtained for mean start latency F(3,31) =
13.67, p < 0.001, and mean distance traveled F(3,31) = 5.97, p < 0.005.
Tukey’s HSD post hoc comparisons revealed a marginally longer mean start latency for
the vehicle-anxiety group compared to the vehicle no-test group (p = 0.092) Mean start latency
for the vehicle-depression group was significantly longer compared to the vehicle no-test group
(p < 0.001), and a shorter mean start latency for the depression-imipramine group compared to
the vehicle-depression group (ps < 0.05). Mean distance traveled for the vehicle-depression
group was shorter compared to the vehicle no-test group (p < 0.005), and the depressionimipramine group revealed a shorter mean distance traveled compared to the vehicle-depression
group (p < 0.05)
0c:100o (Owl Stimulus Cue)
The effects of various drug treatment conditions on start and goal latencies and distance
traveled under the 0c:100o stimulus cue are presented in panels A, B, and C of Figure 12,
respectively. In the vehicle no-test group, mean start latencies were relatively short (e.g., chicks
left the start box in under 30 seconds); whereas, mean goal latencies were very long (e.g., chicks
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reached the goal in approximately 5-min; the cutoff criterion). Mean distance traveled for the
vehicle no-test group was approximately 23 cm, indicating that although most chicks approached
the stimulus cue, they did not reach the goal.
Mean start latency for the vehicle-anxiety group was longer compared to the vehicle notest group, however mean goal latency and mean distance traveled did not differ from the
vehicle no-test group (ps = n.s). Mean start and goal latencies and mean distance traveled for the
anxiety-clonidine group did not differ from the vehicle-anxiety group (ps = n.s.). However, mean
start latency for the clonidine-anxiety group was longer compared to the vehicle no-test group.
In addition, mean distance traveled for the anxiety-clonidine group was shorter compared to the
vehicle no-test group.
Mean start latency for the vehicle-depression group was longer compared to the vehicle
no-test group and this effect was reversed by the depression-imipramine group. Mean goal
latencies for the vehicle-depression and depression-imipramine groups did not groups did not
differ from the vehicle no-test group (ps = n.s.). Mean distance traveled for the vehicledepression group was shorter compared to the vehicle no-test group and this effect was
somewhat reversed by the depression-imipramine group.
Consistent with these observations, a one-way MANOVA revealed a significant
multivariate main effect for treatment, Wilks’ λ = 0.642, F(12,148.45) =2.26, p < 0.05, where p <
0.0125 is considered significant, partial eta squared = 0.137. Power to detect the effect was
0.903. Given the significance of the overall test, the univariate main effects were examined.
Significant univariate main effects for treatment were obtained for mean start latency F(4,58) =
7.30, p < 0.001, and mean distance traveled F(4, 58) = 4.73, p < 0.005.
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Tukey’s HSD post hoc comparisons revealed significantly longer mean start latencies for
the vehicle-anxiety and the anxiety-clonidine groups compared to the vehicle no-test group (ps <
0.05). Mean distance traveled for the anxiety-clonidine group was significantly shorter
compared to the vehicle no-test group (p < 0.05). Mean start latency for the vehicle-depression
group was significantly longer than the vehicle no-test group (p < 0.001), and the mean start
latency for the imipramine-depression group was significantly shorter compared to the vehicledepression group (p < 0.05). Mean distance traveled for the vehicle-depression group was
significantly shorter compared to the no-test group (p < 0.005), and the mean distance traveled
for the imipramine-depression group was marginally longer compared to the vehicle-depression
group (p =0.062).
Discussion
Experiment 2 was conducted to induce cognitive bias under an anxiety-like phase and a
depression-like phase and to test whether those cognitive biases could be pharmacologically
reversed. More specifically, testing whether clonidine could reverse the cognitive bias of more
pessimism observed under the anxiety-like phase. And also, testing whether imipramine could
reverse not only the cognitive bias of more pessimism observed under the anxiety-like phase, but
also the cognitive bias of less optimism observed under the depression-like phase. Distress
vocalizations served as the dependent behavioral measure. And, start and goal latency and
distance traveled served as the dependent measures for the maze.
Distress Vocalizations
The pattern of distress vocalizations is consistent with previous findings in which social
isolation of chicks produces distress vocalizations, a behavioral response to reinstate social
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contact, to identify an anxiety-like (panic-like) phase (i.e., first 5-min of isolation) and
depression-like phase (final 30-60 of isolation) (Sufka et al., 2006). In addition, these two
phases have been pharmacologically reversed using prototypic anxiolytic and antidepressant
drugs. DVoc rates in the anxiety-like phase were significantly attenuated with the administration
of clonidine, an anxiolytic (Warnick et al., 2009), and also with imipramine, an antidepressant
with anxiolytic properties (Sufka et al., 2006). DVoc rates in the depression-like phase remained
relatively high with the administration of imipramine, an antidepressant, which prevents the
onset of behavioral despair and puts the chicks back into a panic-like state (Sufka et al., 2006).
Mirror Stimulus Cue
The vehicle-anxiety group and the anxiety-clonidine group did not reveal any statistically
significant differences from the vehicle no-test group on mean start and goal latencies and on
mean distance traveled under the mirror stimulus cue. These behavioral data are consistent with
the notion that cognitive bias in an anxiety-like state presents as more pessimistic judgments only
under ambiguous aversive cues. The vehicle-depression group displayed significantly longer
mean start and goal latencies under the mirror stimulus cue compared to the vehicle no-test
which is consistent with the notion of less optimism. The depression-imipramine group displayed
significantly shorter mean start and goal latencies compared to the vehicle-depression group
indicating that the cognitive bias of less optimism was reversed by imipramine. This finding is
consistent with imipramine preventing the onset of behavioral despair in the isolation apparatus
thereby putting chicks back into a panic-like state thus reversing less optimistic behavior under
the ambiguous appetitive stimulus cue. In addition, the vehicle-depression group displayed a
marginally significantly shorter mean distance traveled compared to the vehicle no-test group
which is consistent with the notion of less optimism. Further, the depression-imipramine group
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displayed a marginally significantly longer mean distance traveled compared to the vehicledepression group which is consistent with imipramine reversing the cognitive bias of less
optimism.
75c:25o (Ambiguous Chick Stimulus Cue)
The vehicle-anxiety group did not reveal any statistically significant differences from the
vehicle no-test group or the anxiety-clonidine group on mean start and goal latencies and on
mean distance traveled under the 75c:25o (ambiguous chick) stimulus cue. This finding is
consistent with the notion that cognitive bias in an anxiety-like state presents as more pessimistic
judgments to ambiguous aversive cues. Mean start latency for the anxiety-clonidine group was
marginally significantly longer compared to the vehicle no-test group. Although this was an
unexpected finding, given the large amount of animals that needed to be omitted because of clear
sedation, we can only infer that the increased mean start latency is due to the sedative properties
of clonidine where these animals didn’t meet the omission criterion.
The vehicle-depression group displayed significantly longer mean start latencies under
the 75c:25o stimulus cue compared to the vehicle no-test which is consistent with the notion of
less optimism. The depression-imipramine group displayed significantly shorter mean start
latencies compared to the vehicle-depression group indicating that the cognitive bias of less
optimism was reversed by imipramine. This finding is consistent with imipramine preventing
the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a
panic-like state thus reversing less optimistic behavior under the ambiguous appetitive stimulus
cue. In addition, the vehicle-depression group displayed significantly shorter mean distance
traveled which is consistent with the notion of less optimism. No significant drug treatment
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differences were found under mean goal latency which is consistent with previous findings
which indicate that goal latency may not be a sensitive measure of cognitive bias (Salmeto et al.,
in preparation). Further, the depression-imipramine group displayed significantly longer mean
distance traveled compared to the vehicle-depression group which is consistent with imipramine
reversing the cognitive bias of less optimism.
25c:75o (Ambiguous Owl Stimulus Cue)
The vehicle-anxiety group revealed a marginally significant longer mean start latency
compared to the vehicle no-test group under the 25c:75o (ambiguous owl) stimulus cue. This
finding is consistent with the notion of more pessimism. However, the vehicle-anxiety group did
not significantly differ from the vehicle no-test group on mean goal latency and mean distance
traveled. The anxiety-clonidine group did not produce any significant differences compared to
the vehicle-anxiety group on mean start and goal latencies or on mean distance traveled.
The vehicle-depression group displayed longer mean start latencies under the 25c:75o
stimulus cue compared to the vehicle no-test which is consistent with the notion of more
pessimism. The depression-imipramine group displayed significantly shorter mean start
latencies compared to the vehicle-depression group indicating that the cognitive bias of more
pessimism was reversed by imipramine. This finding is consistent with imipramine preventing
the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a
panic-like state thus reversing the cognitive bias of more pessimism observed under the
ambiguous aversive stimulus cue. No significant drug treatment differences were found under
mean goal latency which is consistent with previous findings which indicate that goal latency
may not be a sensitive measure of cognitive bias (Salmeto et al., in preparation). In addition, the
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vehicle-depression group displayed significantly shorter mean distance traveled which is
consistent with the notion of more pessimism. Further, the depression-imipramine group
displayed significantly longer mean distance traveled compared to the vehicle-depression group
which is consistent with imipramine reversing the cognitive bias of more pessimism.
0c:100o (Owl Stimulus Cue)
The vehicle-anxiety group revealed significantly longer mean start latency compared to
the vehicle no-test group under the 0c:100o (owl) stimulus cue which is consistent with the
notion of more pessimism. However, the vehicle-anxiety group did not significantly differ from
the vehicle no-test group on mean goal latency or on mean distance traveled. In addition, the
anxiety-clonidine group did not produce any significant differences compared to the vehicleanxiety group on mean start and goal latencies or on mean distance traveled. However, mean
start latency for the clonidine-anxiety group was significantly longer compared to the vehicle notest group. In addition, mean distance traveled for the anxiety-clonidine group was shorter
compared to the vehicle no-test group. Although these findings were unexpected, given the large
amount of animals that needed to be omitted because of clear sedation, we can only infer that
increased mean start latency and a shorter mean distance traveled are due to the sedative
properties of clonidine where these animals didn’t meet the omission criterion.
The vehicle-depression group displayed longer mean start latencies under the 0c:100o
stimulus cue compared to the vehicle no-test which is consistent with the notion of more
pessimism. The depression-imipramine group displayed significantly shorter mean start
latencies compared to the vehicle-depression group indicating that the cognitive bias of more
pessimism was reversed by imipramine. This finding is consistent with imipramine preventing
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the onset of behavioral despair in the isolation apparatus thereby putting chicks back into a
panic-like state thus reversing the cognitive bias of more pessimism observed under the
ambiguous aversive stimulus cue. No significant drug treatment differences were found under
mean goal latency which is consistent with previous findings which indicate that goal latency
may not be a sensitive measure of cognitive bias (Salmeto et al., in preparation). In addition, the
vehicle-depression group displayed significantly shorter mean distance traveled which is
consistent with the notion of more pessimism. Further, the depression-imipramine group
displayed a marginally significantly longer mean distance traveled compared to the vehicledepression group which is consistent with imipramine reversing the cognitive bias of more
pessimism.
General discussion
Cognitive bias is a phenomenon that presents in individuals suffering from anxiety and/or
depression in which cognitive disturbances elicit negative interpretations of ambiguous stimuli
and/or events. More specifically, anxiety is associated with more pessimistic judgments,
whereas depression is associated with both more pessimistic judgments and less optimistic
judgments (Wright & Bower 1992; MacLeod & Byrne 1996). Interestingly, cognitive bias has
been shown to be sensitive to a variety of therapies affecting mood disturbances including
Cognitive Behavioral Therapy (CBT) (Mathews et al., 1995; Mogg et al., 1995; Segal & Gemar,
1997) and a variety of pharmacotherapies. Following the administration of citrolpam, a serotonin
selective reuptake inhibitor (SSRI), the negative interpretation biases observed in anxious
individuals were ameliorated (Mogg et al., 2004; Weinstein & Nutt, 1995). Further, a single dose
of reboxetine, a norepinephrine selective reuptake inhibitor (NSRI), reversed the negative biases
observed in depressed individuals (Harmer et al., 2009).
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Cognitive bias has previously been examined in the chick anxiety-depression continuum
model using a measure of approach/avoidant behavior to a range of appetitive to aversive
stimulus cues in a straight alley maze (Salmeto et al., in preparation). The observation that
chicks display cognitive bias in this paradigm following social separation stress serves as an
important validation step for the model. The demonstration of reversing the cognitive biases that
presents under the anxiety- and depression-like phases within the maze would provide a further
validation of the chick anxiety-depression continuum model as a neuropsychiatric simulation.
As previously discussed, Experiment 2 sought pharmacologically reverse the cognitive
biases observed under an anxiety-like and a depression-like state. Experiment 2 replicated
previous findings from Salmeto et al. (in preparation) where depressed chicks display the
cognitive bias of less optimism under the appetitive and ambiguous appetitive cues and the
cognitive bias of more pessimism under the aversive and ambiguous aversive cues. These
findings were observed on start latency and distance traveled. However, goal latency did not
prove to be a sensitive measure of cognitive bias which is consistent with previous findings from
Salmeto et al. (in preparation). Therefore we suggest that for future studies goal latency should
be discarded and distance traveled, a more sensitive measure, should be included as a dependent
variable. Or alternatively, lengthening the runway or the time of the test session within the
runway may provide more differentiation between and a better analysis of the dependent
variables. Further, imipramine reversed both forms of cognitive bias in the depression-like phase
under start latency and distance traveled. These findings are consistent with the human clinical
literature in that cognitive biases can be pharmacologically reversed in depressed individuals
(Harmer et al., 2009). More specifically, the administration of a single dose of reboxetine, a
norepinephrine selective reuptake inhibitor, can reverse the negative interpretation biases
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observed within depressed individuals towards emotional information processing or negative
self-referent information compared to controls (Harmer et al., 2009).
Despite using lower doses, the inability of clonidine to reverse the cognitive bias in
anxiety may be related to the sedative nature of the compound. To try to account for sedation,
we excluded data from chicks that were overtly drowsy or fully asleep prior to analysis. This
resulted in lower sample sizes, an increase in error variance, and a decrease in power to detect
significant group differences. Another contributing factor to error variance was the inclusion of
animals that were probably sedated but did not meet the criterion for exclusion. Other
pharmacological options that may be able to reverse the cognitive bias of anxiety include the
benzodiazepines and serotonin selective reuptake inhibitors (SSRIs).
In an attempt to separate the therapeutic effects from the sedative effects of the
benzodiazepine diazepam, Murphy, Downham, Cowen, & Harmer (2008) administered
diazepam at a single low dose that was clinically effective but did not produce sedation in
healthy controls. Upon completion of a battery of emotional processing tasks including facial
expression recognition tasks, attentional dot probe tasks, and startle reflex tasks, among others,
Murphy et al. (2008) concluded that at non-sedating doses, diazepam did not affect mood but did
reveal an increase in positive interpretation in healthy controls. However, when using
benzodiazepine anxiolytics, Golombok et al. (1991) was unable to observe a reversal of negative
interpretation bias in anxious individuals but did reveal an overall slowing of latencies for color
naming on the Stroop task. In addition, Stewart et al. (2000) did not find a reversal of cognitive
bias in anxious individuals after naturalistic benzodiazepine anxiolytic use (i.e. taken on an “as
needed basis”). Consistent with the sedative properties observed in the human literature, a study
by Ennaceur, Michalikova, van Rensburg, & Chazot (2008) revealed that the administration of
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the benzodiazepines diazepam and chlordiazepoxide produced sedation and did not reduce
anxiety in mice (Ennaceur et al., 2008). Thus, benzodiazepines may not be the most appropriate
anxiolytic compound to reverse the cognitive bias seen in anxiety because sedation would cause
runway slowing which would be a large confound. However, SSRIs have been shown to reverse
the cognitive bias of anxiety in the human literature without sedative confounds (Mogg et al.,
2004; Weinstein & Nutt, 1995); therefore, this class of compounds appears to be the most
appropriate for future research on reversing the cognitive bias in anxiety.
Experiment 1 tested the effects of two drug probes on DVoc rates in non-stressed socially
tested chicks, noting these drug treatment groups have not been used in prior validation studies.
However, the pattern of drug effects on DVoc rates is similar to that of isolated chicks whereby
anxiolytics attenuate DVoc rates in the anxiety-like phase and antidepressants elevate the DVoc
rates in the depression-like phase. This finding suggests that the chicks are exposed to some
measurable amount of stress. Early studies suggest that experimenter stress and novelty to an
apparatus are two major contributing factors to stress which may be mitigated by handling and
exposure (Feltenstein et al., 2002). Another contributing factor to stress may have been flock
reduction (e.g., any number lower than 12). Further, the observed pattern of drug effects in
socially tested chicks helps explain the cognitive biases observed under the two ambiguous
stimulus cues (i.e., 75C:25o and 25o:75c) which were also pharmacologically reversed. Testing
drug probes in socially tested chicks has not been examined. This is an avenue of research that
should be further explored to gain a better understanding of the level of stress induced upon the
chicks and prevented by the drug probes administered.
Collectively, the observation that cognitive biases of both more pessimism and less
optimism present within the single test paradigm of anxiety and depression and can be
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pharmacologically reversed in the depression-like phase adds to the validity of the chick anxietydepression model as a neuropsychiatric simulation. The chick anxiety depression model, along
with the runway test to ambiguous appetitive and aversive cues, may lend itself to exploring the
common neurophysiological mechanisms subserving cognitive disturbances and
pharmacological responses seen in these two seemingly related clinical disorders.
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Figure Captions
Figure 1. Diagram and pictures of the Straight alley maze apparatus.
Figure 2. Morphed stimulus cue conditions that blended elements of a chick and a horned owl
silhouette which were defined as: 75c:25o; 75c:25o; 0c:100o. (Note: the 100c:0o and the 50c:50o
will not be used in the current study. They are shown only as a reference).
Figure 3. Mean distress vocalizations as a rate/minute function (+/- SEM) for each drug
treatment condition under the anxiety-like and depression-like phases in panels A and B,
respectively . Sample sizes were n = 28-36. * Indicates a significant decrease compared to the
vehicle condition. ** Indicates a significant increase compared to the vehicle condition.
Figure 4. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the mirror stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 9-12, except of the anxiety-clonidine condition where n = 7. * Indicates
significantly shorter latencies compared to the vehicle isolation-test condition.
Figure 5. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 75c:25o stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 9-10, except for the anxiety-clonidine condition where n = 5. † Indicates a
significant difference compared to the vehicle no-test condition which is interpreted as less
optimism. †† Indicates a significant difference compared to the vehicle isolation-test condition
which is interpreted as a reversal of less optimism.
Figure 6. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 25c:75o stimulus cue in panels A, B, and C respectively. Samples
57

sizes were n = 8-9. * Indicates a significant difference compared to the vehicle no-test condition
which is interpreted as more pessimism. ** Indicates a significant difference compared to the
vehicle isolation-test condition which is interpreted as a reversal of more pessimism.
Figure 7. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 0c:100o stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 6-8, except for the depression-imipramine condition where n = 11. No significant
differences were found.
Figure 8. Mean distress vocalizations as a rate/minute function (+/- SEM) for each drug
treatment condition under the anxiety-like and depression-like phases in panels A and B,
respectively . Sample sizes were n = 48-54, except for the anxiety-clonidine condition where
DVocs were collapsed across both isolation treatment conditions resulting in n = 99. * Indicates
a significant decrease compared to the vehicle condition. ** Indicates a significant increase
compared to the vehicle condition.
Figure 9. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the mirror stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 10-15. † Indicates a significant difference compared to the vehicle no-test
condition which is interpreted as less optimism. †† Indicates a significant difference compared
to the vehicle-depression condition which is interpreted as a reversal of less optimism.
Figure 10. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 75c:25o stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 11-15, except for the anxiety-clonidine condition where n = 7. † Indicates a
significant difference compared to the vehicle no-test condition which is interpreted as less
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optimism. †† Indicates a significant difference compared to the vehicle-depression condition
which is interpreted as a reversal of less optimism.
Figure 11. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 25c:75o stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 11-15, except for the anxiety-clonidine condition where n = 6. * Indicates a
significant difference compared to the vehicle no-test condition which is interpreted as more
pessimism. ** Indicates a significant difference compared to the vehicle-depression condition
which is interpreted as a reversal of more pessimism.
Figure 12. Mean start and goal latencies and mean distance traveled (+/- SEM) for each drug
treatment condition under the 0c:100o stimulus cue in panels A, B, and C respectively. Samples
sizes were n = 12-15, except for the anxiety-clonidine condition where n = 7. * Indicates a
significant difference compared to the vehicle no-test condition which is interpreted as more
pessimism. ** Indicates a significant difference compared to the vehicle-depression condition
which is interpreted as a reversal of more pessimism.
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Figure 6
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Figure 8
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Figure 9
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Figure 11
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